Hypera S.A. Hypera S.A.

Hypera S.A.

HYPE3

Rang in aandelen #4245
Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical... Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical enterprise. The company's comprehensive product line encompasses a wide array of prescription medications, featuring established brands such as Adacne, Celestamine, Cizax, Diprosone, and Emprol XR, among many others. Beyond prescription drugs, Hypera offers specialized dermo-cosmetics through its Mantecorp Skincare brand. Its consumer health division markets popular remedies like Apracur, Benegrip, Engov, and Estomazil. Additionally, Hypera provides nutritional and vitamin supplements, including well-known names such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. The company also maintains a significant presence in the generic and similar medicines market, offering products under the Neo Química brand and common formulations like Ibuprofen, Paracetamol, and Omeprazole. The organization officially became Hypera S.A. in February 2018, having previously operated as Hypermarcas S.A.
Aandeelprijs
$5.33
Marktkapitalisatie
$3.75B
Verandering (1 dag)
2.16%
Verandering (1 jaar)
25.26%
Land
BR
Handel Hypera S.A. (HYPE3)

Categorie

Healthcare
Aandelsplitsingen voor Hypera S.A. (HYPE3)
Het aandeel Hypera S.A. (symbool: HYPE3) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Oct 21, 2026.
Eén aandeel HYPE3 dat vóór Oct 21, 2026 werd gekocht, staat nu gelijk aan 0 aandelen HYPE3.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten